Page 8 - Delta Plus News Today

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China - read this article along with other careers information, tips and advice on BioSpace

DURHAM, N.C. and BEIJING, March 29, 2022 /PRNewswire/ -- Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and... | April 3, 2022

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for...

Researchers investigated the impact of mutations in the SARS-CoV-2 variants of interest and variants of concern on the properties of the cluster of differentiation 8 T lymphocytes.

Global Noise Cancelling Earmuffs market report provides highest data such as opportunities, risk, prime challenges, technological advancement, development strategy, competitive landscape, and...

Even though Covid cases in Uttar Pradesh are on the decline, experts feel that it is still too early to predict the end of the third wave. They feel that safety protocols must be followed.Experts say that the possibility of a new and more ...

/PRNewswire/ -- The "China in Vitro Diagnostics Market, Size, Forecast 2022-2027, Industry Trends, Growth, Share, Impact of COVID-19, Company Analysis" report...

GSK has announced that agreement has been reached with the Irish Government for the supply of Covid-19 treatment Xevudy (sotrovimab), developed in

YORK’S Omicron wave looks to have finally peaked after record numbers of students and children caught the virus - but thousands of residents are…

THE deadly Delta variant of Covid has almost disappeared in York following the rise of Omicron.